Chlamydia pneumoniae infection and coronary heart disease. other infections might have role in South Asians
Tauzeeh, S.M.
Bmj 315(7121): 1539
1997
ISSN/ISBN: 0959-8138 PMID: 9420503 Document Number: 472775
Document emailed within 1 workday
Related Documents
Patel, P.; Mendall, M.A.; Carrington, D.; Strachan, D.P.; Leatham, E.; Molineaux, N.; Levy, J.; Blakeston, C.; Seymour, C.A.; Camm, A.J. 1995: Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors BMJ 311(7007): 711-714Chaudhury, A.; Rajasekhar, D.; Latheef, S.A.A.; Subramanyam, G. 2003: Seropositivity of Chlamydia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in a South Indian population Indian Heart Journal 55(4): 384
Imai, S.; Matsubara, T.; Hori, T.; Nakagawa, I.; Ozaki, K.; Hatada, K.; Mezaki, T.; Nasuno, A.; Kubota, K.; Tanaka, T.; Aizawa, Y. 2001: Relationship of Chlamydia pneumoniae infection to severity of coronary atherosclerosis in patients with chronic coronary artery disease and with normal coronary arteries Journal of Cardiology 37(6): 293-299
Khasaev, A.S.; Gadzhieva, Z.G. 2003: Relationship between Chlamydia pneumoniae and classical risk factors of coronary heart disease Kardiologiia 43(10): 32-34
Al-Ghamdi, A.; Jiman-Fatani, A.A.; El-Banna, H. 2011: Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease Pakistan Journal of Pharmaceutical Sciences 24(2): 95-101
Song, H.; Tasaki, H.; Yashiro, A.; Okazaki, M.; Ioka, T.; Taniguchi, H.; Nakashima, Y. 2001: Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure Clinical Nephrology 56(5): 346-352
Ouchi, K. 2000: The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood Japanese Journal of Antibiotics 53 Suppl B: 13-21
Gajek, J.; Choroszy-Król, I.; Zyśko, D.; Teryks-Wołyniec, D.; Halawa, B.ł 2003: The influence of Chlamydia pneumoniae infection on acute coronary syndromes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(85): 20-23
Cenac, A.; Djibo, A.; Chaigneau, C.; Degbey, H.; Sueur, J.M.; Orfila, J. 2002: Chlamydia pneumoniae et infections respiratoires aiguës chez l'enfant nourri au sein: étude sérologique simultanée mère-enfant à Niamey (Niger) - Chlamydia pneumoniae and acute respiratory tract infections in breast-feeding infants: Simultaneous mother-child serological study in Niamey (Niger) Sante (Montrouge) 12(2): 217-221
Chambers, J.C.; Wander, G.S.; Kooner, J.S. 2000: Homocysteine and coronary heart disease amongst Indian Asians Indian Heart Journal 52(7 Suppl): S5-S8
Fudal, M.; Wilczewski, P.ła. 2004: Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date? Wiadomosci Lekarskie 57(3-4): 151-155
Leowattana, W.; Bhuripanyo, K.; Singhaviranon, L.; Akaniroj, S.; Mahanonda, N.; Samranthin, M.; Pokum, S. 2001: Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial Journal of the Medical Association of Thailand 84 Suppl. 3: S669-S675
Leowattana, W.; Mahanonda, N.; Bhuripunyo, K.; Leelarasamee, A.; Pokum, S.; Suwimol, B. 1999: The prevalence of Chlamydia pneumoniae antibodies in Thai patients with coronary artery disease Journal of the Medical Association of Thailand 82(8): 792-797
Leowattana, W.; Mahanonda, N.; Bhuripanyo, K.; Pokium, S.; Kiartivich, S. 2000: Chlamydia pneumoniae antibodies and angiographically demonstrated coronary artery disease in Thailand Journal of the Medical Association of Thailand 83(9): 1054-1058
Zdrenghea, D.; Bodizs, G.; Taloş, C.; Stanciu, A.; Roşu, R.; Timiş, D.; Aluaş, D. 2000: Chlamydia pneumoniae antibodies and inflammatory reaction in patients with ischemic heart disease Romanian Journal of Internal Medicine 38-39: 51-57
Rottenberg, M.E.; Gigliotti Rothfuchs, A.C.; Gigliotti, D.; Svanholm, C.; Bandholtz, L.; Wigzell, H. 1999: Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice Journal of Immunology 162(5): 2829-2836
Márk, L.ás.ó; Márki-Zay, J.án.; Orosz, I.án.; Kondacs, A.ás.; Erdei, F.; Katona, A.ás. 2003: Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease Orvosi Hetilap 144(16): 765-768
Leowattana, W.; Pokum, S.; Mahanonda, N.; Poungvarin, N. 2001: Rapid detection of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells of coronary artery disease patients by real-time fluorescence PCR Journal of the Medical Association of Thailand 84(Suppl 3): S658-S668
Al Zahmi, F.; Habuza, T.; Awawdeh, R.; Elshekhali, H.; Lee, M.; Salamin, N.; Sajid, R.; Kiran, D.; Nihalani, S.; Smetanina, D.; Talako, T.; Neidl-Van Gorkom, K.; Zaki, N.; Loney, T.; Statsenko, Y. 2021: Ethnicity-Specific Features of COVID-19 Among Arabs, Africans, South Asians, East Asians, and Caucasians in the United Arab Emirates Frontiers in Cellular and Infection Microbiology 11: 773141
Thom, D.H.; Grayston, J.T. 1991: Infections with Chlamydia pneumoniae strain TWAR Clinics in Chest Medicine 12(2): 245-256